Welsbach Technology Metals Acquisition Corp. and Evolution Metals LLC Announce $500 Million PIPE Anchor Equity Investment and $6.2 Billion Debt Facility Term Sheet from Broughton Capital Group
August 01, 2024 17:11 ET
|
Welsbach Technology Metals Acquisition Corp.
Chicago, IL, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Welsbach Technology Metals Acquisition Corp. (NASDAQ: WTMA) (“WTMA”) and Evolution Metals LLC (“EM”) today announced that, inter alios, WTMA and EM...
WalkMe Ltd. Announces Second Quarter 2024 Financial Results
August 01, 2024 16:56 ET
|
WalkMe Inc.
2Q24 Subscription Revenue of $65.7 million an increase of 7% year-over-year.2Q24 Non-GAAP Operating Income of $4.9 million or 7% of total revenues compared to a loss of ($2.3) million or (4%) of total...
Skyward Specialty Achieves “A” (Excellent) Rating Upgrade by AM Best
August 01, 2024 16:49 ET
|
Skyward Specialty Insurance Group, Inc.
HOUSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.TM (Nasdaq: SKWD) ("Skyward Specialty" or "the Company") a leader in the specialty property and casualty (P&C)...
MARA Reports Second Quarter 2024 Results
August 01, 2024 16:35 ET
|
Marathon Digital Holdings Inc.
- Revenues Increase 78% to $145.1 Million- Fair Market Value Loss of $148.0 Million, Resulting in Net Loss of $199.7 Million, or $0.72 Loss per Diluted Share- Adjusted EBITDA Decreases to a Loss...
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
August 01, 2024 16:30 ET
|
Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
Farmers & Merchants Bancorp, Inc. Reports 2024 Second-Quarter and Year-to-Date Financial Results
August 01, 2024 16:30 ET
|
Farmers & Merchants Bancorp, Inc.
ARCHBOLD, Ohio, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2024 second quarter and year-to-date ended June 30,...
Host Hotels & Resorts Provides Updated Second Quarter 2024 Investor Presentation
August 01, 2024 16:30 ET
|
Host Hotels & Resorts, L.P.
BETHESDA, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, today provided an updated...
FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment
August 01, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
La FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLA
August 01, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, 01 août 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière...
The Pennant Group Announces New $250 Million Credit Facility
August 01, 2024 16:21 ET
|
Pennant Group, Inc.
EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today...